Paclitaxel (Taxol) in Breast Cancer
Authors:
- Andrew DorrADAndrew Dorr
- Michael A. FriedmanMFMichael A. Friedman
- 1 February 1994
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 8 (1) , 121-140
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Restoration of Taxol Sensitivity of Multidrug-Resistant Cells by the Cyclosporine SDZ PSC 833 and the Cyclopeptolide SDZ 280-446JNCI: Journal of the National Cancer Institute, 1993
- Phase I Trial of Taxotere: Five-Day ScheduleJNCI: Journal of the National Cancer Institute, 1992
- Mechanism of action of taxolTrends in Pharmacological Sciences, 1992
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI: Journal of the National Cancer Institute, 1990
- Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly.Journal of Cell Biology, 1983
- Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanesBiochemical and Biophysical Research Communications, 1982
- Taxol induces microtubule assembly at low temperatureCell Motility, 1981
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971